Neogenomics NEO
NASDAQ NEO
$19.20 -0.21 (-1.08%)
As of: Sep 22, 2026 · 10:48 AM EDT

Neogenomics (NEO) EBIT Margin (2010 - 2026)

Neogenomics' (NEO) quarterly EBIT Margin came in at 4.85% in Q2 2026, up 2142.0% on a YoY basis from 0.22% in Q2 2025, and up 50.41% quarter-over-quarter from 9.77% in Q1 2026.

Analysis

Neogenomics (NEO) EBIT Margin (2010 - 2026) Analysis & Trends

Neogenomics (NEO) has reported EBIT Margin for 17 consecutive years, with 4.85% the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, EBIT Margin rose 2142.0% year-over-year to 4.85%; the trailing twelve-month figure through Jun 2026 stood at 8.93% (up 776.0% YoY), and the FY2025 full-year result was 15.93%, down 199.0% from the prior year.
  • EBIT Margin advanced to 4.85% in Q2 2026 per NEO's latest filing, from 9.77% in the prior quarter.
  • Across five years, EBIT Margin topped out at 4.85% in Q2 2026 and bottomed at 44.4% in Q1 2022.
  • Historically, EBIT Margin has averaged 18.6% across 5 years, with a median of 16.24% in 2025.
  • The sharpest annual moves came in 2022 and 2026: EBIT Margin sank 3133 bps in 2022, then soared 2142 bps in 2026.
  • Over 5 years, EBIT Margin stood at 19.02% in 2022, then soared by 37 bps to 11.94% in 2023, then gained by 10 bps to 10.7% in 2024, then surged by 34 bps to 7.05% in 2025, then jumped by 31 bps to 4.85% in 2026.
  • According to Business Quant data, EBIT Margin over the past three periods registered 4.85%, 9.77%, and 7.05% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn -10.07%
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn 15.08%
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn 12.10%
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn -38.55%
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn -19.85%
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn 10.21%
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn 34.17%
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn 5.03%
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn -22.04%
10 Neogenomics 2.55 Bn 2.40 Bn 91.88 Mn -4.85%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.85%
Mar 31, 2026 -9.77%
Dec 31, 2025 -7.05%
Sep 30, 2025 -14.38%
Jun 30, 2025 -26.27%
Mar 31, 2025 -16.56%
Dec 31, 2024 -10.70%
Sep 30, 2024 -12.63%
Jun 30, 2024 -13.34%
Mar 31, 2024 -19.56%
Dec 31, 2023 -11.94%
Sep 30, 2023 -15.92%
Jun 30, 2023 -20.35%
Mar 31, 2023 -25.56%
Dec 31, 2022 -19.02%
Sep 30, 2022 -30.68%
Jun 30, 2022 -31.74%
Mar 31, 2022 -44.40%
Dec 31, 2021 -33.06%
Sep 30, 2021 -32.73%
API Access

Neogenomics EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=NEO&period=max&api_key=YOUR_API_KEY